Profile
Mary Sujin Jung has served as Director of Clinical Research and, since 2014, as Director of Clinical Affairs. She leads and coordinates activities across clinical trials, national cardiovascular device development projects, and regulatory compliance.
She brings extensive hands-on experience in executing clinical studies, along with a strong command of intellectual property management and quality assurance under Korean Good Manufacturing Practice (KGMP) standards.
Her multidisciplinary expertise keeps Tau’s clinical operations aligned with regulatory rigor, scientific integrity, and patient‑centered outcomes. She holds a Master’s degree in Biomaterials Engineering.